Pivikto 200 mg Tablet
$385.31
$367.01
Pivikto 200 mg tablet is a potent phosphatidylinositol 3-kinase (PI3K) inhibitor designed for the treatment of advanced hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer in both postmenopausal women and men. This innovative medication is particularly beneficial for patients who have specific mutations in the PIK3CA gene and have not responded to other hormonal therapies. When used in conjunction with fulvestrant, Pivikto can enhance treatment efficacy and provide new hope for those battling this challenging cancer type. It’s essential for patients to discuss any existing health conditions and medications with their healthcare provider, as there are potential interactions and side effects associated with its use. Pivikto’s targeted action offers a modern approach to managing breast cancer, addressing a critical need in oncology. If you or a loved one are navigating advanced breast cancer, Pivikto could be a valuable option worth considering in your treatment plan. Always consult with your oncologist to ensure that Pivikto aligns with your specific medical needs and treatment goals.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Pivikto 200 mg tablet is primarily used in the treatment of breast cancer, particularly in postmenopausal women and men. This medication targets cancer cells, helping to slow their growth and spread. Patients experiencing symptoms such as lumps, changes in breast size, or unusual discharge may benefit from this treatment. By addressing these signs, Pivikto 200 mg tablet plays a crucial role in managing the disease.
• The use of Pivikto 200 mg tablet is essential in hormone receptor-positive breast cancer cases. It works by inhibiting specific pathways that allow cancer cells to thrive. This approach is particularly effective for patients whose cancer has not spread extensively. Regular administration of Pivikto 200 mg tablet can lead to improved outcomes in these scenarios.
• Pivikto 200 mg tablet is often prescribed as part of a comprehensive treatment plan for breast cancer. It may be used in conjunction with other therapies to enhance efficacy. This combination approach helps in addressing various aspects of cancer treatment. Patients under this regimen frequently report a better quality of life while managing their condition.
• In cases of recurrent or metastatic breast cancer, Pivikto 200 mg tablet offers a viable treatment option. It is designed to help manage cancer that has returned or spread beyond the initial site. By utilizing Pivikto 200 mg tablet, healthcare providers aim to control disease progression and improve patient outcomes. This makes it an important choice in ongoing breast cancer management strategies.
Benefits
Breast cancer: Pivikto 200 mg Tablet helps treat breast cancer and may be used alone or in combination with other medicines or treatments, such as chemotherapy. It relieves the symptoms of breast cancer, such as lumps in the breast, bloody discharge from the nipple, or changes in the shape or texture of the breast. Pivikto 200 mg kills or stops the growth of cancer cells and also prevents them from multiplying. Discuss with your doctor if any of the side effects bother you.
Side Effects
As with all medicines, Pivikto 200 mg Tablet has the potential to cause certain side effects. If you experience any of these side effects, it is important to seek immediate medical advice from your doctor. Your doctor will be able to make recommendations on how to effectively manage or minimise the impact of these side effects.
Most Common Side Effects
• Heartburn
• Headache
• Itching
• Dry Skin
• Dry Mouth
• Vaginal Dryness
• Fever
• Swelling of the Arms Or Legs
Common Side Effects
• Nausea
• Vomiting
• Loss of appetite
• Weight loss
• Feeling weak
• Tired
• Mouth sores
• Rash
• Hair loss
• Abnormal blood tests
How To Use
It is recommended that you take Pivikto 200 mg Tablet immediately after a meal. However, for optimal results, it is important to take Pivikto 200 mg Tablet at the same time every day. Your doctor will determine the appropriate dosage and frequency based on your specific condition, which may change over time. It is of the utmost importance that you follow your doctor's instructions and do not change the dosage or frequency without their guidance. Taking Pivikto Tablet in incorrect or excessive amounts can lead to serious side effects. Although it may take several weeks or months for the full effects of treatment to be observed, it is essential to consult your doctor before discontinuing use.
Safety Advice
• Alcohol: The use of alcohol is not recommended while taking Alpelisib Tablet 200 mg due to the increased risk of side effects or possible interference with the effectiveness of Pivikto 200 mg. It is best to consult your doctor or pharmacist before consuming alcohol while taking any medication.
• Kidney: Patients with mild to moderate kidney disease can safely use Pivikto Tablet without dose adjustment. However, caution should be exercised when using this product in patients with severe kidney disease.
• Breastfeeding: The use of Pivikto Tablet while breastfeeding is not recommended as it may pass into breast milk and cause harm to the baby. If you are breastfeeding and taking Alpelisib Tablet 200 mg, it is important to discuss the potential risks and benefits of continuing to breastfeed with your doctor. Your doctor's expertise will help you make an informed decision about the health of both you and your baby.
• Liver: Patients with liver disease can safely use Pivikto 200 mg Tablet without the need to adjust the dose of Pivikto 200 mg. If you experience any side effects, it is recommended that you consult your doctor for further advice.
• Pregnancy: The use of Pivikto 200 mg is not recommended during pregnancy as there is evidence from animal studies of potential harm to the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to discuss the potential risks and benefits of taking Pivikto Tablet during pregnancy with your doctor. Your doctor will be able to help you make an informed decision based on the best interests of both you and your baby.
• Driving: The effect of Pivikto 200 mg on driving performance is not yet known. If you experience symptoms that affect your ability to concentrate and react, it is best not to drive.